NCT03674151

Brief Summary

In plastic and reconstructive surgery, treatment strategies of second-degree burn wounds and split-skin grafted third-degree burn wounds aim at reducing infection and improving reepithelialization. Although previous studies indicate that burn patients benefit from newer wound dressings, only a few studies comparing different wound dressings can be found. Therefore, the aim of this study is to evaluate time to reepithelialization, pain, microbiology, handling and costs of different wound dressings in patients with split-skin grafted third-degree burn wounds.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

January 28, 2017

Completed
1.6 years until next milestone

First Posted

Study publicly available on registry

September 17, 2018

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

February 24, 2023

Status Verified

February 1, 2023

Enrollment Period

10.4 years

First QC Date

January 28, 2017

Last Update Submit

February 22, 2023

Conditions

Keywords

split-skinburn woundwound dressingcomparisonsilverhoneyPVP-Iodhydrogel

Outcome Measures

Primary Outcomes (1)

  • Epithelialization

    Percent of epithelialized area

    through study completion, an average of 1 year

Secondary Outcomes (3)

  • Pain (on a visual analogue scale 0-10)

    through study completion, an average of 1 year

  • Microbiologic Smear

    through study completion, an average of 1 year

  • Subjective Handling

    through study completion, an average of 1 year

Study Arms (4)

Device: Silver Nylon dressing

ACTIVE COMPARATOR

1/4 of a split-skin grafted third-degree burn wound in a Group (n=20): Consent-capable male and female patients ≥18 years of age who have a split-skin grafted third-degree burn on ≥3% and ≤30% of the surface of the body.

Device: Silver Nylon dressing

Device: Manuka-Honey

ACTIVE COMPARATOR

1/4 of a split-skin grafted third-degree burn wound in a Group (n=20): Consent-capable male and female patients ≥18 years of age who have a split-skin grafted third-degree burn on ≥3% and ≤30% of the surface of the body.

Device: Manuka-Honey

Device: Povidone-Iod (PVP-Iod)

ACTIVE COMPARATOR

1/4 of a split-skin grafted third-degree burn wound in a Group (n=20): Consent-capable male and female patients ≥18 years of age who have a split-skin grafted third-degree burn on ≥3% and ≤30% of the surface of the body.

Device: Povidone-Iod (PVP-Iod)

Device: Hydrogel

ACTIVE COMPARATOR

1/4 of a split-skin grafted third-degree burn wound in a Group (n=20): Consent-capable male and female patients ≥18 years of age who have a split-skin grafted third-degree burn on ≥3% and ≤30% of the surface of the body.

Device: Hydrogel

Interventions

Non-staining Silver Nylon dressing with a permanently plated metallic surface on split-skin grafted third-degree burn wound

Device: Silver Nylon dressing

Manuka-Honey dressing on split-skin grafted third-degree burn wound

Device: Manuka-Honey

Povidone-Iod (PVP-Iod) dressing on split-skin grafted third-degree burn wound

Device: Povidone-Iod (PVP-Iod)
HydrogelDEVICE

Hydrogel dressing on split-skin grafted third-degree burn wound

Device: Hydrogel

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consent-capable male and female patients
  • ≥18 years of age
  • ≥3% and ≤30% total body surface area (TBSA) split-skin grafted third-degree burn
  • appropriate form of wound (not: too small) and localization (not: face, inplane surface)
  • ability to asses pain

You may not qualify if:

  • Immunosuppressive Therapy
  • Clinical wound infection
  • Allergy against porcine material, bee poison or honey, etherial oil, propyleneglycol, silver, nylon
  • Relationship to someone who is involved in the study design or assessment
  • Participation in other clinical trials
  • Citizen of countries outside Europe

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Schleswig-Holstein

Lübeck, Schleswig-Holstein, 23538, Germany

RECRUITING

MeSH Terms

Conditions

Burns

Interventions

Bandages, Hydrocolloid

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

BandagesEquipment and Supplies

Study Officials

  • Tobias Kisch, MD

    University Hospital Schleswig-Holstein

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Reinhard Vonthein, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 28, 2017

First Posted

September 17, 2018

Study Start

July 1, 2015

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

February 24, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations